HIV Prevention, Vaccine Research Progressing

In a guest post on the Center for Global Health Policy’s “Science Speaks” blog, Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI), and William Snow, director of the Global HIV Vaccine Enterprise, discuss the recent AIDS Vaccine 2012 Conference that was held in Boston. “There has been so much progress in every aspect of HIV prevention research over the last three years that [researchers] had plenty to report,” they write, adding, “[I]t is increasingly clear that defeating HIV will require the combined application of a number of interventions.” They review the results of several studies and comments from several speakers and conclude, “[S]cientific partnership across borders and oceans has long been a hallmark of HIV vaccine development. That, after all, is what brought the field to where it is now: on the verge of a transformation” (Barton, 10/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.